Tag: science

A science journal pulled a controversial study about a bizarre life form against the authors’ wishes

A microscopic discovery in a California lake sparked buzz and controversy more than a decade ago when it was first revealed.

Scientists said they’d discovered bacteria that used the element arsenic — poisonous to life as we know it — to grow. If true, it expanded the possibilities for where life could exist on Earth — or on other worlds.

Several research groups failed to replicate the results, and argue it’s not possible for a living thing to use something so toxic to make DNA and proteins. Some scientists have suggested the results of the original experiments may have been skewed by undetected contaminants.

On Thursday, the journal Science, which first published the research, retracted it, though not because of misconduct on the researchers’ part.

“If the editors determine that a paper’s reported experiments do not support its key conclusions, even if no fraud or manipulation occurred, a retraction is considered appropriate,” the journal’s editor-in-chief Holden Thorp wrote in the statement announcing the retraction.

The researchers disagree with the journal’s decision and stand by their data. It’s reasonable to pull a paper for major errors or suspected misconduct — but debates and disagreements over the findings are part of the scientific process, said study co-author Ariel Anbar of Arizona State University.

Keep reading

Scientists in Maryland Are Developing Artificial Blood

Scientists in Maryland believe they are on the verge of creating artificial blood that could save thousands of lives.

Researchers and scientists at the University of Maryland School of Medicine in Baltimore are creating artificial blood by extracting hemoglobin from expired blood and then enclosing the protein in a bubble of fat, which replicates red blood cells.

Dr. Allan Doctor shared that the artificial blood is “designed so that at the moment it’s needed, a medic can mix it with water, and within a minute, you have blood.”

Currently, the team at the University of Maryland School of Medicine is using artificial blood in tests with rabbits.

Per NPR:

Tens of thousands of people bleed to death each year in the United States before they can get to a hospital. That’s because ambulances, medical helicopters and military medics can’t routinely carry blood, which would go bad too fast without adequate refrigeration.

So scientists have been on a quest to develop artificial blood that could be stored in powdered form and reconstituted by medics on the spot to save lives.

At the University of Maryland School of Medicine in Baltimore, where some of this research is being conducted, a white rabbit lies on the floor of a cage. It’s in a “special intensive care unit that we’ve created for our rabbit resuscitation,” says Dr. Allan Doctor, a scientist at the school.

Doctor’s team just drained blood from the animal to simulate what happens to a person who’s hemorrhaging from an injury, such as from a car crash or battlefield wound. “This rabbit is still in shock. You can see he’s lying very still. It’s as if he was at the scene of an accident,” says Doctor. “If we didn’t do anything, it would die.”

But Doctor and his team are going to save this rabbit today. They’re going to fill his veins with something they hope will finally enable them to achieve a goal that has stymied researchers for decades: developing safe and effective artificial blood. “Good bunny,” says Danielle Waters, a technician on Doctor’s team, as she gently lifts the rabbit and starts infusing him with three big syringes of artificial blood.

Keep reading

NIH Director Details Crackdown on Fees Monopoly Publishers Charge

In an exclusive interview with The DisInformation Chronicle, National Institutes of Health Director Jay Bhattacharya explains his latest policy to control monopoly science publishers now raking in hundreds of millions of dollars from taxpayers, while sometimes playing partisan politics and pushing fake narratives. The NIH announced yesterday that they will soon cap the “article processing fees” that publishers can charge NIH-funded researchers to make their studies public and available to American taxpayers.

NIH funds much of the planet’s biomedical science, but this research has remained locked up by pricey science journals that charge Americans expensive fees to read the results of the very studies they funded. The publishers of Science Magazine, for example, demand $30 to read a single study.

However, this changed recently when Dr. Bhattacharya demanded that journals make NIH-funded studies public as soon as they publish them. However, taxpayers are still on the hook, paying the “open access fee” that journals charge scientists.

In the case of the esteemed Nature Magazine, this means a $12,600 fee. Of course, scientists don’t have thousands of dollars lying around for publishing fees, so NIH-funded researchers simply charge that cost back to the American taxpayer as part of their NIH grants. In effect, taxpayers get charged twice: first when they fund an NIH grant for a university professor, and second when they pay that professor’s publishing fee to a science journal.

And this money quickly adds up.

The six largest science publishers charge researchers $1.8 billion in publishing fees every year, with American taxpayers soaking up a large portion of that money. NIH’s latest policy will control these costs in the future, ensuring more NIH money goes to scientists and their research.

Keep reading

Giant, flightless bird is next target for de-extinction company Colossal Biosciences


A species of huge, flightless bird that once inhabited New Zealand disappeared around 600 years ago, shortly after human settlers first arrived on the country’s two main islands. Now, a Texas-based biotech company says it has a plan to bring it back.

Genetic engineering startup Colossal Biosciences has added the South Island giant moa — a powerful, long-necked species that stood 10 feet (3 meters) tall and may have kicked in self-defense — to a fast-expanding list of animals it wants to resurrect by genetically modifying their closest living relatives.

The company stirred widespread excitement, as well as controversy, when it announced the birth of what it described as three dire wolf pups in April. Colossal scientists said they had resurrected the canine predator last seen 10,000 years ago by using ancient DNA, cloning and gene-editing technology to alter the genetic make-up of the gray wolf, in a process the company calls de-extinction. Similar efforts to bring back the woolly mammoth, the dodo and the thylacine, better known as the Tasmanian tiger, are also underway.

To restore the moa, Colossal Biosciences announced Tuesday it would collaborate with New Zealand’s Ngāi Tahu Research Centre, an institution based at the University of Canterbury in Christchurch, New Zealand, that was founded to support the Ngāi Tahu, the main Māori tribe of the southern region of New Zealand.

The project would initially involve recovering and analyzing ancient DNA from nine moa species to understand how the giant moa (Dinornis robustus) differed from living and extinct relatives in order to decode its unique genetic makeup, according to a company statement.

“There is so much knowledge that will be unlocked and shared on the journey to bring back the iconic moa,” Ben Lamm, CEO and co-founder of Colossal Biosciences, said in the statement. For example, the company said, researching the genomes of all moa species would be “valuable for informing conservation efforts and understanding the role of climate change and human activity in biodiversity loss.”

Keep reading

1900 Scientists Say ‘Climate Change Not Caused by CO2’ – The Real Environment Movement Was Hijacked

Millions of people worldwide are concerned about climate change and believe there is a climate emergency. For decades we have been told by the United Nations that Carbon dioxide (CO2) emissions from human activity are causing disastrous climate change. In 2018, a UN IPCC report even warned that ‘we have 12 years to save the Earth’, thus sending millions of people worldwide into a frenzy. 

Thirty-five years ago, the United Nations Environment Programme (UNEP) and the (World Meteorological Organization) WMO established the Intergovernmental Panel on Climate Change (IPCC) to provide scientific advice on the complex topic of climate change. The panel was asked to prepare, based on available scientific information, a report on all aspects relevant to climate change and its impacts and to formulate realistic response strategies. The first assessment report of the IPCC served as the basis for negotiating the United Nations Framework Convention on Climate Change (UNFCCC). Governments worldwide have signed this convention, thereby, significantly impacting the lives of the people of the world.

However, many scientists dispute with the UN-promoted man-made climate change theory, and many people worldwide are confused by the subject, or are unaware of the full facts. Please allow me to provide some information you may not be aware of.

Keep reading

How Big Pharma Hijacked Evidence-Based Medicine

I. Introduction

Evidence-Based Medicine (EBM) is a relatively recent phenomenon. The term itself was not coined until 1991. It began with the best of intentions — to give frontline doctors the tools from clinical epidemiology to make science-based decisions that would improve patient outcomes. But over the last three decades, EBM has been hijacked by the pharmaceutical industry to serve the interests of shareholders rather than patients.

Today, EBM gives preference to epistemologies that favor corporate interests while instructing doctors to ignore other valid forms of knowledge and their own professional experience. This shift disempowers doctors and reduces patients to objects while concentrating power in the hands of pharmaceutical companies. EBM also leaves doctors ill-equipped to respond to the autism epidemic and unable to produce the sorts of paradigm-shifts that would be necessary to address this crisis.

In this article I will:

  • provide a brief history of EBM;
  • explain how evidence hierarchies work;
  • explore ten general and technical criticisms of EBM and evidence hierarchies;
  • examine the American Medical Association’s 2002, 2008, and 2015 evidence hierarchies;
  • highlight the corporate takeover of EBM; and
  • explore the implications of these dynamics for the autism epidemic.

Keep reading

Eight Healthy Babies Born via IVF using DNA from Three People

In the United Kingdom, medical professionals have successfully delivered eight babies using a pioneering fertility procedure that incorporates DNA from three individuals.

This method aims to safeguard children from inheriting severe mitochondrial disorders. The births represent a cautious advancement in assisted reproduction, prioritizing family health and stability.

The mothers involved carried mutations in their mitochondria, risking life-threatening conditions for their offspring. Mitochondria serve as cellular energy sources, essential for bodily functions. Without intervention, these defects could devastate future generations.

The United Kingdom amended its laws in 2015 to permit this technique, reflecting deliberate ethical review. In 2017, regulators issued the initial license to Newcastle University’s fertility clinic. This institution led the development over two decades.

Among the newborns are four boys and four boys, including identical twins, from seven women. All show no evidence of the anticipated mitochondrial ailments. One additional pregnancy continues under medical care.

Professor Doug Turnbull, a key researcher, described the results as reassuring for families and scientists alike. He highlighted the relief in achieving positive outcomes for patients.

Professor Mary Herbert, a senior team member, expressed fulfillment in seeing eight healthy infants. She noted the achievement rewards the extensive collaborative work.

Human genes primarily reside in the cell’s nucleus, totaling around 20,000. However, mitochondria add 37 genes of their own. Faulty mutations here can lead to profound cellular energy deficits.

Keep reading

Researchers Have Cracked the 4,500-Year-Old Genome of a Mummy From Egypt’s First Pyramid Age

An ancient Egyptian genome has finally been unraveled after four decades of study, thanks to a sample collected from a mummy dating back to the time of the first pyramids.

The achievement marks the first complete sequencing of a genome of such antiquity collected from the region. The genetic data revealed information about the movement of people over millennia, as 80% of the individual’s DNA corresponds to ancient North Africans, while 20% is related to ancient West Asians.

The remains reveal a story of a hard life of manual labor, lived by an individual who possibly belonged to an ancient Egyptian pottery community.

A Decades-Long Genetic Quest

Forty years ago, Svante Pääbo, a Nobel Prize-winning Swedish geneticist, conducted the first successful extraction of ancient Egyptian DNA, although his work only resulted in a partial sequence. Now, scientists at the Francis Crick Institute and Liverpool John Moores University (LJMU) have conducted the first complete sequencing after working with the oldest Egyptian DNA sample ever collected.

“Forty years have passed since the early pioneering attempts to retrieve DNA from mummies without successful sequencing of an ancient Egyptian genome,” said co-author Pontus Skoglund, Group Leader of the Ancient Genomics Laboratory at the Francis Crick Institute. “Ancient Egypt is a place of extraordinary written history and archaeology, but challenging DNA preservation has meant that no genomic record of ancestry in early Egypt has been available for comparison.” 

“Building on this past research, new and powerful genetic techniques have allowed us to cross these technical boundaries and rule out contaminating DNA, providing the first genetic evidence for potential movements of people in Egypt at this time,” Skoglund added.

Keep reading

MIT Invents “Bubble Wrap” That Pulls Fresh Water From The Air…Even In The Driest Places In The World

MIT researchers have invented a new water-harvesting device — a high-tech version of “bubble wrap” — that can pull safe drinking water straight from the air, even in extreme environments like Death Valley, the driest desert in North America, according to LiveScience.

In a study published June 11 in Nature Water, the team described how their innovation could help address global water scarcity. “It works wherever you may find water vapor in the air,” the researchers wrote.

The device is built from hydrogel, a material that can absorb large amounts of water, sandwiched between two glass layers resembling a window. At night, the hydrogel draws moisture from the air. During the day, a special coating on the glass keeps it cool, allowing water to condense and drip into a collection system.

The hydrogel is molded into dome shapes — likened to “a sheet of bubble wrap” — that swell when absorbing moisture. These domes increase surface area, helping the material absorb more water.

LiveScience writes that the system was tested for a week in Death Valley, a region spanning California and Nevada that holds the record as the hottest and driest place in North America.

Despite the harsh conditions, the harvester consistently produced between 57 and 161.5 milliliters of water daily — about a quarter to two-thirds of a cup. In more humid regions, researchers expect even greater yields. According to MIT representatives, this approach outperforms earlier water-from-air technologies and does so without needing electricity.

One major breakthrough was solving a known problem with hydrogel-based water harvesters: lithium salts used to improve absorption often leak into the water, making it unsafe. The new design adds glycerol, which stabilizes the salt and keeps leakage to under 0.06 parts per million — a level the U.S. Geological Survey deems safe for groundwater.

Though a single panel can’t supply an entire household, its small footprint means several can be installed together. The team estimates that eight 3-by-6-foot (1-by-2-meter) panels could provide enough drinking water for a household in areas lacking reliable sources. Compared to the cost of bottled water in the U.S., the system could pay for itself in under a month and remain functional for at least a year.

Keep reading

Meet The Dystopian Startups Making ‘Biological Computers’ From Human Cells

Picture a dystopian future where computers don’t just mimic human thinking – they’re powered by actual human brain cells. That future is taking shape in a Cambridge, England, lab, where a groundbreaking device called CL1 is blending biology and technology in ways that could transform how we compute. Developed by Australian startup Cortical Labs and U.K.-based bit.bio, this shoebox-sized machine houses 200,000 lab-grown brain cells wired to silicon circuits, creating a “biological computer” that’s already turning heads.

Unlike traditional computers, which guzzle energy, CL1 operates with the efficiency of a human brain. “Our brains process information using a fraction of the power that modern electronics need,” Hon Weng Chong, CEO of Cortical Labs, told FT. “This could open doors to smarter robots, stronger cybersecurity, and immersive virtual worlds.”

Oh, joy.

Low-energy computing has fueled a race to develop biological systems, with Cortical Labs leading alongside competitors like FinalSpark in Switzerland and Biological Black Box in the U.S.CL1’s brain cells, grown from human skin-derived stem cells, are carefully arranged in layers: one type sparks electrical activity, while another keeps it in check. “It’s like balancing a gas pedal and brakes,” Chong explains. This precision, says bit.bio’s Tony Oosterveen, gives CL1 an edge over rival approaches using less uniform “mini-brains.” The result is a platform for testing how brain cells handle information, with early experiments already yielding insights for neuroscience and drug development.

Keep reading